Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening



Status:Completed
Conditions:Other Indications, Women's Studies
Therapuetic Areas:Other, Reproductive
Healthy:No
Age Range:18 - 50
Updated:1/19/2018
Start Date:January 20, 2017
End Date:January 12, 2018

Use our guide to learn which trials are right for you!

Use of a Novel Decision Aid for Prenatal Aneuploidy Screening

The investigators aim to assess whether use of a novel, tablet-based computerized decision
aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit
in improving patient knowledge and decreasing decisional conflict.

184 women will be randomized in a 1:1 fashion to use of a novel computerized iPad-based
decision aid in addition to routine counseling or routine counseling only during a single
study visit. This decision aid was developed at a 10th grade literacy level using input from
Maternal Fetal Medicine physicians and certified genetic counselors, and piloted by 20
English and Spanish speaking women of varying education levels. Following completion of
genetic counseling, participants will complete several surveys assessing knowledge and
decision conflict. Data will be abstracted regarding demographics, screening and diagnostic
testing uptake, and testing results.

Inclusion Criteria:

- Pregnancy at less than 22 weeks gestation

- English or Spanish speaking

- Undergoing genetic counseling at North Carolina Women's Hospital for aneuploidy
screening

Exclusion Criteria:

- Known fetal anomalies

- Known multiple gestations

- Prior genetic counseling or aneuploidy screening in current pregnancy
We found this trial at
1
site
Chapel Hill, North Carolina 27599
(919) 962-2211
University of North Carolina at Chapel Hill Carolina’s vibrant people and programs attest to the...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials